Ayurvedic management of Uterine leiomyoma
Phase 2
- Conditions
- Health Condition 1: D259- Leiomyoma of uterus, unspecified
- Registration Number
- CTRI/2022/05/042372
- Lead Sponsor
- Seed Grant
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Married women who are diagnosed with uterine fibroid on USG or CT
2. Fibroid size <7 cm
Exclusion Criteria
1. Unmarried
2. Menopausal
3. PID
4. Carcinoma
5. Fibroid size > 7 cm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment will be done on the basis of <br/ ><br>fibroid size seen in USG or CT, <br/ ><br>Relief in lower abdominal pain, <br/ ><br>Decrease in the amount of Menstrual bleeding, <br/ ><br>Duration of Menstruation, <br/ ><br>Interval of Menstrual CycleTimepoint: Pretreatment <br/ ><br>4th week - 1st Follow up <br/ ><br>8th week - 2nd Follow up <br/ ><br>12th week - 3rd Follow up
- Secondary Outcome Measures
Name Time Method Fibroid Size <br/ ><br>Amount of Menstrual bleeding <br/ ><br>Duration of Menstruation <br/ ><br>Interval of Menstrual CycleTimepoint: 1 month after completion of treatment <br/ ><br>6 months after completion of treatment